Literature DB >> 12925966

Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.

Esther de Vries1, Freddie I Bray, Jan Willem W Coebergh, Donald M Parkin.   

Abstract

We analyzed time trends in incidence of and mortality from malignant cutaneous melanoma in European populations since 1953. Data were extracted from the EUROCIM database of incidence data from 165 cancer registries. Mortality data were derived from the WHO database. During the 1990s, incidence rates were by far highest in northern and western Europe, whereas mortality was higher in males in eastern and southern Europe. Melanoma rates have been rising steadily, albeit with substantial geographic variation. In northern Europe, a deceleration in these trends occurred recently in persons aged under 70. Joinpoint analyses indicated that changes in these trends took place in the early 1980s. In western Europe, mortality rates have also recently leveled off [estimated annual percentage change (EAPC) from -13.6% (n.s.) to 3.3%], whereas in eastern and southern Europe both incidence and mortality rates are still increasing [incidence EAPCs 2.3-8.9%, mortality EAPCs -1.8% (n.s.) to 7.2%]. Models including the effects of age, period and birth cohort were required to adequately describe the rising incidence trends in most European populations, with a few exceptions. Time trends in mortality were adequately summarized on fitting either an age-cohort model (with the leveling off of rates starting in birth cohorts between 1930 and 1940) or an age-period-cohort model. The most plausible explanations for the deceleration or decline in the incidence and mortality trends in recent years in northern (and to a lesser extent western) Europe are earlier detection and more frequent excision of pigmented lesions and a growing public awareness of the dangers of excessive sunbathing. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12925966     DOI: 10.1002/ijc.11360

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  61 in total

1.  Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?

Authors:  Susana Puig; Joaquim Marcoval; Cristina Paradelo; Antoni Azon; Ramon Bartralot; Susana Bel; Xavier Bigata; Aram Boada; Antoni Campoy; Cristina Carrera; Neus Curco; Joan Dalmau; Carlos Ferrándiz; Josep R Ferreres; Manel Formigon; Fernando Gallardo; Alberto Gonzalez; Miquel Just; Enric Llistosella; Rosa M Marti; M Elena Nogues; Ramon Pedragosa; Josep A Pujol; Rodrigo Roldán-Marín; Mireia Sabat; Montserrat Salleras; Juan A Smandia; Pedro Zaballos; Estel Plana; Josep Malvehy
Journal:  Acta Derm Venereol       Date:  2015-04       Impact factor: 4.437

2.  Adolescents' Attitudes to Sun Exposure and Sun Protection.

Authors:  Teresa Fernández-Morano; Francisco Rivas-Ruiz; Magdalena de Troya-Martín; Nuria Blázquez-Sánchez; Maria Padilla Ruiz; Agustín Buendía-Eisman
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

3.  Melanoma incidence has risen in Europe.

Authors:  Esther de Vries; Jan-Willem W Coebergh
Journal:  BMJ       Date:  2005-09-24

Review 4.  Improving outcomes in advanced malignant melanoma: update on systemic therapy.

Authors:  Sarah Danson; Paul Lorigan
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Treatment of melanoma.

Authors:  Claus Garbe; Patrick Terheyden; Ulrich Keilholz; Oliver Kölbl; Axel Hauschild
Journal:  Dtsch Arztebl Int       Date:  2008-12-05       Impact factor: 5.594

6.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

7.  [Malignant melanoma].

Authors:  J Göhl; W Hohenberger; S Merkel
Journal:  Chirurg       Date:  2009-06       Impact factor: 0.955

8.  Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.

Authors:  Haike M J van der Velden; Michelle M van Rossum; Willeke A M Blokx; Jan B M Boezeman; Marie-Jeanne P Gerritsen
Journal:  Dermatol Res Pract       Date:  2009-12-31

9.  Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.

Authors:  Milena Casula; Antonio Muggiano; Antonio Cossu; Mario Budroni; Corrado Caracò; Paolo A Ascierto; Elena Pagani; Ignazio Stanganelli; Sergio Canzanella; Mariacristina Sini; Grazia Palomba; Giuseppe Palmieri
Journal:  BMC Cancer       Date:  2009-10-03       Impact factor: 4.430

Review 10.  A systematic review of health-related quality of life in cutaneous melanoma.

Authors:  D Cornish; C Holterhues; L V van de Poll-Franse; J W Coebergh; T Nijsten
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.